The bell tolls for German health minister
This article was originally published in Scrip
Executive Summary
There are those in this world who are clearly masters of their own destiny and those who are oracles of their own doom. German health minister Philip Rösler apparently has a foot in both camps. When he was catapulted into his post ahead of some of his Liberal Party (FDP) colleagues in October 2009, Dr Rösler was aware that Germany stood on the brink of a comprehensive health reform that was aimed at easing the crippling €10 billion deficit of the statutory health insurance system. Daunting as the task may have seemed at the time, Dr Rösler felt he was up to it. He may now be regretting his overenthusiasm.
You may also be interested in...
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.
EMA Acts To Freeze GVK Drugs, Guard Against Shortages
The EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.
EMA Acts To Freeze Drugs Linked to GVK Bio, Guards Against Shortages
EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.